Vivos Therapeutics (VVOS) Q3 2025 Earnings

Aug 19Confirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-1.05
-0.83
-0.6
-0.38

Details

Expected EPS
-0.38
Actual EPS
-0.55
Surprise EPS
-0.17
Surprise Percent
-44.74%

Description

⁨Vivos Therapeutics⁩ (⁦VVOS⁩) has reported earnings of ⁦-0.55⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts